Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Vose

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphomaD A Stewart, J M Vose, D D Weisenburger, et al.
Blood|January 15, 1994
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograftM R Bishop, J R Anderson, J D Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphomaJ M Vose, J O Armitage, D D Weisenburger, et al.
Infection Control and Hospital Epidemiology|March 1, 1993
Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplantsP C Iwen, E C Reed, J O Armitage, et al.
Blood|October 15, 1992
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-upJ M Vose, P J Bierman, J R Anderson, et al.
The American Journal of Medicine|September 1, 1989
Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantationJ M Vose, J O Armitage, P J Bierman, et al.
Experimental Hematology|December 1, 1995
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxisS Martin-Algarra, M R Bishop, S Tarantolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's diseaseP J Bierman, J M Vose, P K Leichner, et al.
American Journal of Hematology|June 22, 2000
Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study GroupD D Weisenburger, J M Vose, T C Greiner, et al.
Cancer|January 1, 1993
Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patientsB G Gordon, D D Weisenburger, P I Warkentin, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphomaD A Stewart, J M Vose, D D Weisenburger, et al.
Blood|January 15, 1994
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograftM R Bishop, J R Anderson, J D Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphomaJ M Vose, J O Armitage, D D Weisenburger, et al.
Infection Control and Hospital Epidemiology|March 1, 1993
Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplantsP C Iwen, E C Reed, J O Armitage, et al.
Blood|October 15, 1992
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-upJ M Vose, P J Bierman, J R Anderson, et al.
The American Journal of Medicine|September 1, 1989
Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantationJ M Vose, J O Armitage, P J Bierman, et al.
Experimental Hematology|December 1, 1995
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxisS Martin-Algarra, M R Bishop, S Tarantolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's diseaseP J Bierman, J M Vose, P K Leichner, et al.
American Journal of Hematology|June 22, 2000
Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study GroupD D Weisenburger, J M Vose, T C Greiner, et al.
Cancer|January 1, 1993
Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patientsB G Gordon, D D Weisenburger, P I Warkentin, et al.
Pageof 14